Member LoginDividend CushionValue Trap
|
Fundamental data is updated weekly, as of the prior weekend. Please download the Full Report and Dividend Report for
any changes.
Latest
Valuentum Commentary
Jan 16, 2019
Markets Still Bouncing Nicely
Image shown: This holiday season was mighty hectic, and not many were anticipating the volatility we experienced. Here's where the simulated Best Ideas Newsletter and simulated Dividend Growth Newsletter portfolios went to "fully invested," reducing a 30% and 20% cash "weighting" at the high end of their respective ranges for each portfolio, respectively. No Changes to Simulated Newsletter portfolios Jan 14, 2019
Value Trap, More Volatility; We're Waiting and Watching
Image shown: The decision to remove GE from the simulated newsletter portfolios when we did may have been our best call yet. In this note, let's talk about the importance of reading Value Trap, learn why we've gone "fully invested," talk a little bit about put options, learn some of the intricacies of the Valuentum process, find out where to find VBI rankings to download and sort, and talk about some of our recently-highlighted ideas in the simulated newsletter portfolios. No Changes to Simulated Newsletter portfolios. Jan 9, 2019
The Intricacies of the Valuentum Process
Let’s take a quick overview of the Valuentum processes for capital appreciation and dividend growth with a discussion of how we use the Valuentum Buying Index and the Dividend Cushion ratio. Jan 9, 2019
Catching the Bottom?
Image shown: The depths of how far the S&P 500 (SPY) has fallen more recently, and the timing of the decision to move to being "fully invested" in simulated Best Ideas Newsletter portfolio and simulated Dividend Growth Newsletter portfolio. No Changes to Simulated Newsletter portfolios. This article was sent to members via email January 9. Jan 4, 2019
Markets Up Big; Upside Volatility
Image shown: The S&P 500 ETF (SPY) since August 2017. The index has broken through support and is now bouncing back to resistance. Dec 31, 2018
Valuentum Stock Screeners
Brian Nelson provides members with an update on Valuentum's stock screeners and the significant number of forward-looking data we provide. This article was sent to members via email December 29. Dec 20, 2018
Market Mayhem -- Alerts for Members
Dear members -- we released a number of emails today. Please read and let us know if you have any questions. We're here for you. Nov 28, 2018
Cardinal Health Battling Bottom-Line Headwinds
Image Source: Global Panorama. Healthcare product distributor and Dividend Aristocrat Cardinal Health has had its share price performance in 2018 dampened by a number of factors, including generic drug price deflation weighing on its ‘Pharmaceutical’ segment, struggles in its ‘Medical’ segment, and the potential for disruption within its industry. Sep 27, 2018
HCA Healthcare - Building Out a Healthcare Network
Image Source: HCA second-quarter 2018 Investor Update. We are becoming increasingly intrigued by the consolidation occurring in the hospital sector as HCA Healthcare is well on its way to developing a dominant position in some of the more populated states in the US. Sep 5, 2018
There Is Milk At The Store
"Now this is not the end. It is not even the beginning of the end. But it is, perhaps, the end of the beginning." -- Winston Churchill Latest News and Media The High Yield Dividend Newsletter, Best Ideas
Newsletter, Dividend Growth Newsletter, Nelson Exclusive publication, and any reports, articles and content found on
this website are for information purposes only and should not be considered a solicitation to buy or sell any
security. The sources of the data used on this website are believed by Valuentum to be reliable, but the data’s
accuracy, completeness or interpretation cannot be guaranteed. Valuentum is not responsible for any errors or
omissions or for results obtained from the use of its newsletters, reports, commentary, or publications and accepts
no liability for how readers may choose to utilize the content. Valuentum is not a money manager, is not a
registered investment advisor and does not offer brokerage or investment banking services. Valuentum, its employees,
and affiliates may have long, short or derivative positions in the stock or stocks mentioned on this site.
|
